Thinking of joining a study?

Register your interest

NCT06523166 | NOT YET RECRUITING | Device Related Thrombosis


Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics
Sponsor:

University Hospitals Cleveland Medical Center

Information provided by (Responsible Party):

Steven Filby, MD

Brief Summary:

The current standard of care for patients who underwent left atrial appendage closure (LAAC) is to have follow-up transesophageal echocardiogram (TEE) for device surveillance. TEE is an ultrasound of the heart done by placing a probe in the esophagus under conscious sedation. It does not use contrast but can be cumbersome to patients as it involves placing a probe in the esophagus. Cardiac computerized tomography angiography (cardiac CTA) is a non-invasive imaging modality that involves the use of certain types of x-rays, contrast (dye) and special computers to generate accurate images of the heart. Participants in this study will undergo both TEE and CTA on the same day 90 days after their LAAC procedure. Participants will be in this research study for a period of 1 year, starting from the day of their scheduled LAAC procedure. Participants will undergo a TEE at 90 days after their procedure which is the standard of care imaging study after LAAC. As part of this study, participants will also undergo a cardiac CTA at 90 days as well. Participants will have a routine follow-up visit following device placement as per standard of care as well as a brief phone "check in" at 1 year.

Condition or disease

Device Related Thrombosis

Peri-device Leak

Intervention/treatment

Transesophageal echocardiography (TEE)

Cardiac CTA

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 320 participants
Masking : NONE
Primary Purpose : DIAGNOSTIC
Official Title : Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics: A Multicenter Study
Actual Study Start Date : 2025-06-01
Estimated Primary Completion Date : 2025-10-31
Estimated Study Completion Date : 2025-10-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Subjects \>18 years old planned to undergo LAAC
  • * eGFR ≥ 30 mL/min per 1.73 m2
Exclusion Criteria
  • * Subjects below the age of 18
  • * non-English speaking subjects
  • * eGFR \< 30 mL/min per 1.73 m2
  • * Subjects with history of contrast allergy
  • * Pregnant women

Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics

Location Details

NCT06523166


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

United States, California

Cedars Sinai

Los Angeles, California, United States, 90048

Not yet recruiting

United States, New York

St. Francis Hospital and Catholic Health

Roslyn, New York, United States, 11576

Not yet recruiting

United States, North Carolina

Sanger Heart & Vascular Institute- Atrium Health

Charlotte, North Carolina, United States, 28277

Not yet recruiting

United States, Ohio

University Hospitals Cleveland Medical Center

Cleveland, Ohio, United States, 44106

Not yet recruiting

United States, Ohio

Ohio State University Medical Center

Columbus, Ohio, United States, 43210

Loading...